$4.36 Billion is the total value of Avidity Partners Management LP's 82 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 32.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $231,179,000 | -5.8% | 3,499,000 | -5.4% | 5.31% | +3.8% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $223,459,000 | +56.9% | 793,000 | +45.3% | 5.13% | +73.0% |
| ARGX | Buy | ARGENX SEsponsored adr | $216,909,000 | +290.9% | 572,500 | +225.3% | 4.98% | +330.8% |
| ANTM | Buy | ELEVANCE HEALTH INC | $212,818,000 | +8.5% | 441,000 | +10.4% | 4.89% | +19.6% |
| AVTR | Buy | AVANTOR INC | $206,899,000 | +7.9% | 6,652,700 | +17.4% | 4.75% | +19.0% |
| LLY | New | LILLY ELI & CO | $197,780,000 | – | 610,000 | +100.0% | 4.54% | – |
| HUM | Buy | HUMANA INC | $192,985,000 | +123.0% | 412,300 | +107.3% | 4.43% | +145.8% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $170,980,000 | +32.6% | 725,600 | +0.9% | 3.92% | +46.1% |
| JNJ | Buy | JOHNSON & JOHNSON | $159,795,000 | +154.7% | 900,200 | +154.3% | 3.67% | +180.9% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $148,106,000 | +24.4% | 1,856,900 | +64.1% | 3.40% | +37.2% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $143,062,000 | +31.6% | 1,467,600 | +26.5% | 3.28% | +45.1% |
| ARVN | Buy | ARVINAS INC | $141,238,000 | -28.0% | 3,355,623 | +15.1% | 3.24% | -20.6% |
| XBI | Buy | SPDR SER TRs&p biotech | $139,256,000 | +252.1% | 1,875,000 | +326.1% | 3.20% | +288.5% |
| MCK | Buy | MCKESSON CORP | $126,830,000 | +118.6% | 388,800 | +105.2% | 2.91% | +141.1% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $124,401,000 | -6.0% | 242,200 | -6.7% | 2.86% | +3.6% |
| ABBV | Sell | ABBVIE INC | $115,636,000 | -51.3% | 755,000 | -48.5% | 2.66% | -46.4% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $104,858,000 | +25.1% | 5,450,000 | +13.0% | 2.41% | +37.9% |
| CTLT | Buy | CATALENT INC | $102,462,000 | +18.1% | 955,000 | +22.1% | 2.35% | +30.2% |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $100,763,000 | -31.3% | 3,585,881 | +12.9% | 2.31% | -24.2% |
| SGEN | Buy | SEAGEN INC | $97,317,000 | +575.6% | 550,000 | +450.0% | 2.23% | +644.7% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $94,107,000 | +77.6% | 2,525,000 | +111.1% | 2.16% | +95.8% |
| BIIB | Buy | BIOGEN INC | $89,849,000 | +16.9% | 440,566 | +20.7% | 2.06% | +28.9% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $88,267,000 | +39.9% | 1,479,500 | +70.3% | 2.03% | +54.2% |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $69,997,000 | – | 1,035,000 | +100.0% | 1.61% | – |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $58,240,000 | +105.5% | 1,125,194 | +188.5% | 1.34% | +126.6% |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $55,000,000 | +38.2% | 1,000,000 | -8.7% | 1.26% | +52.4% |
| ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $50,667,000 | +15.4% | 1,438,999 | +50.7% | 1.16% | +27.2% |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $50,369,000 | +23.5% | 1,350,000 | -1.0% | 1.16% | +36.2% |
| NTRA | Buy | NATERA INC | $48,521,000 | -8.3% | 1,369,100 | +5.3% | 1.11% | +1.2% |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $44,266,000 | – | 775,504 | +100.0% | 1.02% | – |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $41,027,000 | +36.3% | 2,972,947 | +10.5% | 0.94% | +50.2% |
| BLU | Buy | BELLUS HEALTH INC NEW | $39,409,000 | +55.4% | 4,265,000 | +15.7% | 0.90% | +71.4% |
| ALT | Buy | ALTIMMUNE INC | $34,878,000 | +99.9% | 2,981,000 | +4.0% | 0.80% | +120.7% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $33,494,000 | -42.7% | 4,050,000 | +15.1% | 0.77% | -36.8% |
| RNA | Buy | AVIDITY BIOSCIENCES INC | $30,225,000 | -20.0% | 2,080,200 | +1.7% | 0.69% | -11.7% |
| KRTX | New | KARUNA THERAPEUTICS INC | $25,880,000 | – | 204,570 | +100.0% | 0.59% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $25,824,000 | – | 1,325,000 | +100.0% | 0.59% | – |
| ARKG | New | ARK ETF TRgenomic rev etf | $23,618,000 | – | 750,000 | +100.0% | 0.54% | – |
| VIR | Sell | VIR BIOTECHNOLOGY INC | $19,312,000 | -3.7% | 758,211 | -2.8% | 0.44% | +6.0% |
| NKTX | New | NKARTA INC | $17,421,000 | – | 1,414,082 | +100.0% | 0.40% | – |
| PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $16,203,000 | -38.8% | 1,919,800 | -1.3% | 0.37% | -32.5% |
| Buy | CARIBOU BIOSCIENCES INC | $16,019,000 | -38.1% | 2,950,000 | +4.6% | 0.37% | -31.7% | |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $15,780,000 | – | 1,200,000 | +100.0% | 0.36% | – |
| NUVB | Sell | NUVATION BIO INC | $15,730,000 | -38.4% | 4,855,000 | -0.0% | 0.36% | -32.1% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $15,371,000 | -84.7% | 1,392,300 | -77.0% | 0.35% | -83.2% |
| XENE | New | XENON PHARMACEUTICALS INC | $13,689,000 | – | 450,000 | +100.0% | 0.31% | – |
| SIBN | SI-BONE INC | $13,200,000 | -41.6% | 1,000,000 | 0.0% | 0.30% | -35.7% | |
| SPNE | SEASPINE HLDGS CORP | $11,357,000 | -53.5% | 2,010,000 | 0.0% | 0.26% | -48.7% | |
| ATEC | Sell | ALPHATEC HLDGS INC | $11,216,000 | -64.3% | 1,715,000 | -37.3% | 0.26% | -60.8% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $9,722,000 | -8.9% | 215,000 | +2.4% | 0.22% | +0.5% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $9,673,000 | – | 62,000 | +100.0% | 0.22% | – |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $8,498,000 | -21.5% | 998,565 | -17.3% | 0.20% | -13.3% |
| EPIX | ESSA PHARMA INC | $7,749,000 | -49.0% | 2,460,000 | 0.0% | 0.18% | -43.8% | |
| IPSC | CENTURY THERAPEUTICS INC | $7,266,000 | -33.3% | 865,000 | 0.0% | 0.17% | -26.4% | |
| CYT | CYTEIR THERAPEUTICS INC | $5,532,000 | -20.7% | 1,850,000 | 0.0% | 0.13% | -12.4% | |
| ERASCA INC | $5,542,000 | -35.2% | 995,000 | 0.0% | 0.13% | -28.7% | ||
| AN2 THERAPEUTICS INC | $5,335,000 | -48.6% | 688,330 | 0.0% | 0.12% | -43.5% | ||
| CMPX | COMPASS THERAPEUTICS INC | $5,300,000 | +93.4% | 2,000,000 | 0.0% | 0.12% | +114.0% | |
| MSAC | MEDICUS SCIENCES ACQUISITION | $5,086,000 | 0.0% | 520,000 | 0.0% | 0.12% | +10.4% | |
| BLSA | BCLS ACQUISITION CORP | $4,950,000 | +0.3% | 500,000 | 0.0% | 0.11% | +10.7% | |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $4,905,000 | +0.1% | 500,000 | 0.0% | 0.11% | +10.8% | |
| PANA | PANACEA ACQUISITION CORP II | $4,880,000 | +0.1% | 500,000 | 0.0% | 0.11% | +9.8% | |
| S | SENTINELONE INCcl a | $4,771,000 | -39.8% | 204,500 | 0.0% | 0.11% | -33.3% | |
| ISEE | Sell | IVERIC BIO INC | $4,138,000 | -96.2% | 430,117 | -93.4% | 0.10% | -95.8% |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $3,984,000 | +0.5% | 400,000 | 0.0% | 0.09% | +9.6% | |
| Buy | TANGO THERAPEUTICS INC | $3,686,000 | -32.6% | 813,640 | +12.8% | 0.08% | -25.4% | |
| HYPERFINE INC | $3,353,000 | -37.0% | 1,503,754 | 0.0% | 0.08% | -30.6% | ||
| CMAX | CAREMAX INC | $2,742,000 | -51.4% | 755,329 | 0.0% | 0.06% | -46.2% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $2,643,000 | -54.5% | 4,405,000 | 0.0% | 0.06% | -49.6% | |
| FIELD TRIP HEALTH LTD | $2,500,000 | -37.3% | 2,976,000 | 0.0% | 0.06% | -31.3% | ||
| ONCS | ONCOSEC MED INC | $2,185,000 | -35.5% | 2,945,000 | 0.0% | 0.05% | -29.6% | |
| OTIC | Sell | OTONOMY INC | $2,080,000 | -35.8% | 1,000,000 | -25.9% | 0.05% | -28.4% |
| DNAC | SOCIAL CAP SUVRETTA HLD CRPI | $1,990,000 | +0.5% | 200,000 | 0.0% | 0.05% | +12.2% | |
| DNAB | SOCIAL CAP SUVRETTA HLDS CRP | $1,944,000 | -0.3% | 200,000 | 0.0% | 0.04% | +9.8% | |
| DNAD | SOCIAL CAP SUVRETTA HLDS CP | $1,942,000 | -0.3% | 200,000 | 0.0% | 0.04% | +9.8% | |
| GRPH | GRAPHITE BIO INC | $1,953,000 | -46.1% | 710,000 | 0.0% | 0.04% | -40.0% | |
| DNAA | SOCIAL CAP SUVRETTA HLDS CRP | $1,978,000 | 0.0% | 200,000 | 0.0% | 0.04% | +9.8% | |
| SCYX | Buy | SCYNEXIS INC | $1,785,000 | -16.1% | 959,524 | +76.4% | 0.04% | -6.8% |
| SEMA4 HOLDINGS CORP | $1,197,000 | -59.0% | 950,000 | 0.0% | 0.03% | -55.7% | ||
| SCIENCE 37 HOLDINGS INC | $864,000 | -62.5% | 430,000 | 0.0% | 0.02% | -58.3% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $28,000 | -63.2% | 99,999 | 0.0% | 0.00% | -50.0% | |
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $10,000 | -60.0% | 57,770 | 0.0% | 0.00% | -100.0% | |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -560,000 | -100.0% | -0.05% | – |
| HLXA | Exit | HELIX ACQUISITION CORP | $0 | – | -400,000 | -100.0% | -0.09% | – |
| DYNS | Exit | DYNAMICS SPECIAL PURPOSE COR | $0 | – | -500,000 | -100.0% | -0.10% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -215,000 | -100.0% | -0.28% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -291,184 | -100.0% | -0.39% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -1,040,000 | -100.0% | -0.40% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -104,000 | -100.0% | -0.48% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -912,000 | -100.0% | -0.60% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -711,000 | -100.0% | -0.61% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -1,175,000 | -100.0% | -0.61% | – |
| INSM | Exit | INSMED INC | $0 | – | -1,354,539 | -100.0% | -0.66% | – |
| BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -1,694,700 | -100.0% | -0.81% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -440,000 | -100.0% | -1.08% | – |
| ACET | Exit | ADICET BIO INC | $0 | – | -3,120,000 | -100.0% | -1.30% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -325,000 | -100.0% | -2.04% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -1,393,000 | -100.0% | -2.38% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -1,231,000 | -100.0% | -3.04% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -1,915,500 | -100.0% | -3.09% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -2,370,000 | -100.0% | -4.05% | – |
| Exit | SPDR SER TRcall | $0 | – | -3,300,000 | -100.0% | -6.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 15 | Q3 2023 | 4.6% |
| ARVINAS INC | 14 | Q3 2023 | 4.9% |
| ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
| SYNDAX PHARMACEUTICALS INC | 14 | Q3 2023 | 3.2% |
| IDEAYA BIOSCIENCES INC | 13 | Q3 2023 | 2.5% |
| NATERA INC | 13 | Q3 2023 | 1.9% |
| ALPINE IMMUNE SCIENCES INC | 13 | Q3 2023 | 0.5% |
| ABBVIE INC | 12 | Q2 2023 | 9.7% |
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 3.4% |
| AVANTOR INC | 11 | Q1 2023 | 6.0% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adicet Bio, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ALPINE IMMUNE SCIENCES, INC. | February 14, 2023 | 1,888,887 | 4.0% |
| ESSA Pharma Inc. | February 14, 2023 | 1,855,400 | 4.2% |
| Gritstone bio, Inc. | February 14, 2023 | 2,859,971 | 3.3% |
| IVERIC bio, Inc. | February 14, 2023 | 838,407 | 0.6% |
| ONCOSEC MEDICAL IncSold out | February 14, 2023 | 0 | 0.0% |
| PhaseBio Pharmaceuticals Inc | February 14, 2023 | 2,040,000 | 4.1% |
| Phathom Pharmaceuticals, Inc. | February 14, 2023 | 1,900,000 | 4.6% |
| Viridian Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Anika Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-09 |
| SC 13G | 2024-03-27 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.